[High-dose daptomycin use in methicillin-resistant Staphylococcus aureus disseminated infection]

L Escosa-García; O Ramilo; A Mejías

doi:10.1016/j.anpedi.2012.07.005

[High-dose daptomycin use in methicillin-resistant Staphylococcus aureus disseminated infection]

An Pediatr (Barc). 2013 Mar;78(3):185-8. doi: 10.1016/j.anpedi.2012.07.005. Epub 2012 Sep 12.

[Article in Spanish]

Authors

L Escosa-García¹, O Ramilo, A Mejías

Affiliation

¹ Unidad de Infectología Pediátrica, Hospital Infantil Universitario, La Paz, Madrid, España. luisescosa1983@hotmail.com

PMID: 22981640
DOI: 10.1016/j.anpedi.2012.07.005

Abstract

Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) infections are an increasing problem in our country. Daptomycin is a bactericidal antibiotic with activity against CA-MRSA. Experience using high-dose daptomycin is reviewed in three paediatric patients with severe-disseminated CA-MRSA infection with a favourable microbiological and clinical response.

Publication types

Case Reports
English Abstract

MeSH terms

Anti-Bacterial Agents / therapeutic use*
Child
Daptomycin / administration & dosage*
Female
Humans
Male
Methicillin-Resistant Staphylococcus aureus*
Staphylococcal Infections / drug therapy*

Substances

Anti-Bacterial Agents
Daptomycin